Showing 1 to 6 of 6 results
Liquid Biopsy Speeds Cancer Diagnosis, Improves Patient Outcomes
A 41-year-old woman, Rebeca Proctor, diagnosed with stage 4 lung cancer in January, credits a rapid liquid biopsy which confirmed her cancer's genetic variant ten days sooner than a tissue biopsy, enabling immediate treatment with Brigatinib and significantly improving her quality of life; NHS Engla...
Liquid Biopsy Speeds Cancer Diagnosis, Improves Patient Outcomes
A 41-year-old woman, Rebeca Proctor, diagnosed with stage 4 lung cancer in January, credits a rapid liquid biopsy which confirmed her cancer's genetic variant ten days sooner than a tissue biopsy, enabling immediate treatment with Brigatinib and significantly improving her quality of life; NHS Engla...
Progress
44% Bias Score
Liquid Biopsy Shows Promise for Early Detection and Prevention of Breast Cancer Relapse
A new blood test, "liquid biopsy," detects breast cancer relapse earlier than traditional methods, allowing for preventive treatment with camizestrant, showing a 56% reduction in disease progression risk in a clinical trial involving 3000 patients.
Liquid Biopsy Shows Promise for Early Detection and Prevention of Breast Cancer Relapse
A new blood test, "liquid biopsy," detects breast cancer relapse earlier than traditional methods, allowing for preventive treatment with camizestrant, showing a 56% reduction in disease progression risk in a clinical trial involving 3000 patients.
Progress
48% Bias Score
Liquid Biopsies: Revolutionizing Cancer Treatment
Liquid biopsies, blood tests detecting tumor traces, are transforming cancer treatment by enabling earlier detection and personalized therapies; however, high costs and complex analysis limit widespread adoption in Spain, where their use is most advanced in lung, colon, and rectal cancers.
Liquid Biopsies: Revolutionizing Cancer Treatment
Liquid biopsies, blood tests detecting tumor traces, are transforming cancer treatment by enabling earlier detection and personalized therapies; however, high costs and complex analysis limit widespread adoption in Spain, where their use is most advanced in lung, colon, and rectal cancers.
Progress
28% Bias Score
Cancer Treatment Breakthroughs Extend Patient Survival
Several breakthroughs in cancer treatment were announced, including new immunotherapies significantly increasing survival rates for head and neck, melanoma, and gastric cancers; Car T-cell therapy showing 40% longer survival in advanced gastric cancer; liquid biopsies enabling faster, personalized t...
Cancer Treatment Breakthroughs Extend Patient Survival
Several breakthroughs in cancer treatment were announced, including new immunotherapies significantly increasing survival rates for head and neck, melanoma, and gastric cancers; Car T-cell therapy showing 40% longer survival in advanced gastric cancer; liquid biopsies enabling faster, personalized t...
Progress
28% Bias Score
NHS to Roll Out Revolutionary Blood Test for Faster Lung Cancer Diagnosis
The NHS will roll out a new ultra-sensitive blood test, called a liquid biopsy, to help diagnose lung cancer and fast-track patients to targeted treatments, potentially saving £11 million annually and transforming cancer care.
NHS to Roll Out Revolutionary Blood Test for Faster Lung Cancer Diagnosis
The NHS will roll out a new ultra-sensitive blood test, called a liquid biopsy, to help diagnose lung cancer and fast-track patients to targeted treatments, potentially saving £11 million annually and transforming cancer care.
Progress
52% Bias Score
New Blood Test Improves Pancreatic Cancer Diagnosis and Treatment
A new blood test, PAC-MANN, accurately diagnoses pancreatic cancer 98% of the time by detecting protease enzyme activity, offering earlier detection and improved treatment options; when combined with the CA 19-9 test, accuracy for early detection increases to 85%.
New Blood Test Improves Pancreatic Cancer Diagnosis and Treatment
A new blood test, PAC-MANN, accurately diagnoses pancreatic cancer 98% of the time by detecting protease enzyme activity, offering earlier detection and improved treatment options; when combined with the CA 19-9 test, accuracy for early detection increases to 85%.
Progress
44% Bias Score
Showing 1 to 6 of 6 results